Kuwait Anti-infective Agents Market Size & Outlook
Kuwait anti-infective agents market, 2018-2030 (US$M)
Related Markets
Kuwait anti-infective agents market highlights
- The Kuwait anti-infective agents market generated a revenue of USD 251.8 million in 2024 and is expected to reach USD 227.3 million by 2030.
- The Kuwait market is expected to grow at a CAGR of -1% from 2025 to 2030.
- In terms of segment, antivirals was the largest revenue generating type in 2024.
- Antifungals is the most lucrative type segment registering the fastest growth during the forecast period.
Anti-infective agents market data book summary
| Market revenue in 2024 | USD 251.8 million |
| Market revenue in 2030 | USD 227.3 million |
| Growth rate | -1% (CAGR from 2025 to 2030) |
| Largest segment | Antivirals |
| Fastest growing segment | Antifungals |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibacterials, Antivirals, Antifungals |
| Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.2% of the global anti-infective agents market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa anti-infective agents market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 935.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-infective Agents Market Scope
Anti-infective Agents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait anti-infective agents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 63.82% in 2024. Horizon Databook has segmented the Kuwait anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait's anti-infective agents market is experiencing growth, driven by the rising prevalence of infectious diseases. According to the National Institutes of Health (NIH), the prevalence of HIV among intravenous drug users (IDUs) in Kuwait was 4.6% in 2022, highlighting the need for effective treatments.
The country's growing pharmaceutical industry further supports this market expansion, with key players such as SPIMACO and Jamjoom Pharma contributing to the development and distribution of anti-infective drugs. These efforts, combined with increased awareness and healthcare investments, are propelling the demand for innovative solutions in Kuwait's healthcare sector.
Reasons to subscribe to Kuwait anti-infective agents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait anti-infective agents market databook
-
Our clientele includes a mix of anti-infective agents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait anti-infective agents market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait anti infective agents market size, by type, 2018-2030 (US$M)
Kuwait Anti-infective Agents Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
